Genta Announces New Appointments
Ana Stancic and Dr. Marvin E. Jaffe to join Genta’s board. Douglas Watson to retire.
Read MoreAna Stancic and Dr. Marvin E. Jaffe to join Genta’s board. Douglas Watson to retire.
Read MoreNew published preclinical data highlights activity of MEDI-573 as inhibitor of dual pathways that regulate the development and progression of cancer
Read MoreDispute is in regards to Abbott’s commercialization obligations related to Depomed’s post-herpetic neuraligia pain med, DM-1796.
Read MoreChina State Institute of Pharmaceutical Industry to finance 100% of product development in China.
Read MoreCompany says it’s on track to proceed to a Phase II/III clinical trial in critical limb ischemia under a Joint FDA-EMA protocol, and a Phase II clinical trial in intermittent claudication.
Read More